Literature DB >> 12615309

Tick-borne encephalitis.

T S Gritsun1, V A Lashkevich, E A Gould.   

Abstract

Tick-borne encephalitis (TBE) is one of the most dangerous human infections occurring in Europe and many parts of Asia. The etiological agent Tick-borne encephalitis virus (TBEV), is a member of the virus genus Flavivirus, of the family Flaviviridae. TBEV is believed to cause at least 11,000 human cases of encephalitis in Russia and about 3000 cases in the rest of Europe annually. Related viruses within the same group, Louping ill virus (LIV), Langat virus (LGTV) and Powassan virus (POWV), also cause human encephalitis but rarely on an epidemic scale. Three other viruses within the same group, Omsk hemorrhagic fever virus (OHFV), Kyasanur Forest disease virus (KFDV) and Alkhurma virus (ALKV), are closely related to the TBEV complex viruses and tend to cause fatal hemorrhagic fevers rather than encephalitis. This review describes the clinical manifestations associated with TBEV infections, the main molecular-biological properties of these viruses, and the different factors that define the incidence and severity of disease. The role of ticks and their local hosts in the emergence of new virus variants with different pathogenic characteristics is also discussed. This review also contains a brief history of vaccination against TBE including trials with live attenuated vaccine and modern tendencies in developing of vaccine virus strains.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615309     DOI: 10.1016/s0166-3542(02)00206-1

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  157 in total

1.  Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses.

Authors:  Michael R Holbrook; Robert E Shope; Alan D T Barrett
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

Review 2.  The role of chemokines in the pathogenesis of neurotropic flaviviruses.

Authors:  Susana V Bardina; Jean K Lim
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

3.  High-throughput procedure for tick surveys of tick-borne encephalitis virus and its application in a national surveillance study in Switzerland.

Authors:  Rahel Gäumann; Kathrin Mühlemann; Marc Strasser; Christian M Beuret
Journal:  Appl Environ Microbiol       Date:  2010-05-07       Impact factor: 4.792

4.  NIAID workshop on Flavivirus immunity.

Authors:  Alison D Augustine; M Cristina Cassetti; Francis A Ennis; Eva Harris; William H Hildebrand; Patricia M Repik
Journal:  Viral Immunol       Date:  2010-06       Impact factor: 2.257

5.  Tick-borne Encephalitis Vaccines.

Authors:  Axel T Lehrer; Michael R Holbrook
Journal:  J Bioterror Biodef       Date:  2011

Review 6.  Neurologic aspects of infections in international travelers.

Authors:  May H Han; Joseph R Zunt
Journal:  Neurologist       Date:  2005-01       Impact factor: 1.398

7.  Neuropathogenesis and neurovirulence of live flaviviral vaccines in monkeys.

Authors:  Inessa Levenbook; Ken Draper
Journal:  J Virol       Date:  2009-05       Impact factor: 5.103

Review 8.  Louping ill virus: an endemic tick-borne disease of Great Britain.

Authors:  C L Jeffries; K L Mansfield; L P Phipps; P R Wakeley; R Mearns; A Schock; S Bell; A C Breed; A R Fooks; N Johnson
Journal:  J Gen Virol       Date:  2014-02-19       Impact factor: 3.891

9.  Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers.

Authors:  Peter F Wright; Sharon Ankrah; Susan E Henderson; Anna P Durbin; Jim Speicher; Stephen S Whitehead; Brian R Murphy; Alexander G Pletnev
Journal:  Vaccine       Date:  2008-01-04       Impact factor: 3.641

10.  Identification of genetic determinants of a tick-borne flavivirus associated with host-specific adaptation and pathogenicity.

Authors:  Dana N Mitzel; Sonja M Best; Max F Masnick; Stephen F Porcella; James B Wolfinbarger; Marshall E Bloom
Journal:  Virology       Date:  2008-09-26       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.